ECO Animal Health eyes Japanese market

Animal drugs developer ECO Animal Health is eyeing further opportunities for sales and profit growth after securing two significant developments in the market for Aivlosin® in Japan.

ECO has been granted a further indication to its marketing authorisation for Aivlosin Premix for pigs from the Japanese Ministry of Agriculture, Forestry and Fisheries.

This new Aivlosin marketing authorisation, for the treatment and prevention of the enteric (digestive) disease ileitis, complements the existing indication for mycoplasmal respiratory disease.

In addition, and as part of its global marketing programme, ECO has appointed ASKA Pharmaceutical Company Ltd, a major animal health and pharmaceutical company as its new distributor for Aivlosin in Japan.

ECO Animal Health chairman, Peter Lawrence said the two separate but linked developments would further strengthen ECO's position in a very important and stable market segment.

He added that it was a further step towards establishing ECO as a major supplier of veterinary pharmaceutical products for farmed and domestic animals in the region.